DJIA 18,053.71 23.50 0.13%
NASDAQ 4,806.86 33.39 0.70%
S&P 500 2,088.77 6.89 0.33%
market minute promo


company name or ticker
Company Photos
(Click to zoom)

Biotech Stock Roundup: Geron Soars on $935M J&J Deal, Gilead's Harvoni Approved in the EU - Analyst

Biotech Stock Roundup: Geron Soars on $935M J&J Deal, Gilead's Harvoni Approved in the EU - Analyst Blog

3 Drugs Stocks Driving The Industry Higher

Merck IMPROVEs-IT Causing These Biotechs' Stock Prices to Improve Too

Thanks to Merck, Regeneron Pharmaceuticals and Esperion Therapeutics likely won't have to run outcomes studies on their cholesterol drugs.

US Stock Futures Mostly Flat Ahead Of Housing Data

Cramer's Mad Money - Globalstar Defends Itself (11/17/14)

Jim Cramer's Top Stock Picks: REGN CST MPC LULU

Jim Cramer's 'Mad Money' Recap: When Bad News Is Really Good News for Us

Nasdaq 100 Movers: VIP, MYL

Why Novartis and Regeneron Care About This Tiny Biotech Stock

Ophthotech's Fovista may tip the scale in favor of either Novartis' Lucentis or Regeneron's Eylea.

Biotech: And Yet We've Just Begun...

See More Articles...